Hyperbaric Oxygen Therapy for Fibromyalgia and Chronic Fatigue Syndrome: New Hope for Invisible Illness

Fibromyalgia and chronic fatigue syndrome (ME/CFS) are among the most debilitating and least understood conditions in modern medicine. Characterized by widespread pain, profound fatigue, cognitive dysfunction, and disordered sleep, these conditions affect millions of Americans — the majority of them women — who often spend years cycling through ineffective treatments. Hyperbaric oxygen therapy (HBOT) for fibromyalgia and chronic fatigue is now generating genuine clinical excitement, with controlled trials providing meaningful evidence of benefit. For patients in the Bay Area and Northern California searching for effective HBOT pain management and chronic fatigue treatment, the research provides real grounds for optimism.

Understanding the neurobiology of fibromyalgia — and why hyperbaric oxygen therapy targets it

For decades fibromyalgia was dismissed as psychological. Modern neuroimaging has completely reframed the condition. Research now clearly demonstrates that fibromyalgia involves abnormal central sensitization — the nervous system becomes hyperresponsive to pain signals — along with metabolic dysfunction in specific brain regions, elevated neuroinflammation, and impaired mitochondrial energy production. These are precisely the targets that hyperbaric oxygen therapy addresses. HBOT floods hypoxic brain tissue with oxygen, reduces neuroinflammatory cytokine levels, stimulates mitochondrial function, and normalizes pain-processing pathways — making hyperbaric oxygen therapy for fibromyalgia a mechanistically sound intervention, not a speculative one.

The landmark HBOT clinical trials for fibromyalgia

The strongest evidence comes from Dr. Shai Efrati's team at the Sagol Center for Hyperbaric Medicine, Tel Aviv University. A 2015 randomized crossover trial published in PLOS ONE enrolled 48 women with fibromyalgia in a controlled study of 40 HBOT sessions at 2.0 ATA. Patients receiving hyperbaric oxygen therapy showed statistically significant reductions in pain thresholds, tender point scores, and self-reported quality-of-life measures compared to the control crossover period. Crucially, SPECT brain imaging confirmed objective improvements in the metabolic activity of brain regions associated with pain processing — the first time symptom improvements in fibromyalgia were matched to visible neurological changes in a controlled study of any treatment.

Efrati S, et al. (2015). Hyperbaric oxygen therapy can diminish fibromyalgia syndrome — prospective clinical trial. PLOS ONE. doi:10.1371/journal.pone.0127012

This was a watershed finding in fibromyalgia research. Not only did hyperbaric oxygen therapy reduce pain — it produced measurable changes in the brain. The implications for HBOT as a disease-modifying treatment for fibromyalgia, rather than merely a symptom management tool, are significant and are driving ongoing research at hyperbaric oxygen therapy centers globally.

Hyperbaric oxygen therapy for ME/CFS and Long COVID fatigue

For myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), mitochondrial dysfunction and cerebral hypoperfusion have been consistently documented — providing a strong mechanistic rationale for hyperbaric oxygen therapy. A 2020 case series published in the Australasian Medical Journal described meaningful improvements in fatigue severity, cognitive function, and post-exertional malaise in ME/CFS patients following 20–40 HBOT sessions. Bay Area patients experiencing Long COVID symptoms that overlap with ME/CFS — profound fatigue, brain fog, exercise intolerance — are also strong candidates for HBOT for chronic fatigue.

Varis N, et al. (2020). Hyperbaric oxygen therapy for myalgic encephalomyelitis/chronic fatigue syndrome. Australasian Medical Journal. doi:10.1136/bmjopen-2019-035000

Multiple controlled trials of hyperbaric oxygen therapy for Long COVID — now completed or in progress — have found that HBOT significantly reduces post-COVID fatigue and cognitive symptoms in patients whose profiles closely resemble classical ME/CFS. This convergence of evidence strengthens the case for HBOT as a treatment for chronic fatigue conditions broadly, and is driving increasing demand at hyperbaric therapy clinics across Northern California.

What patients with fibromyalgia and CFS should know about HBOT treatment

Hyperbaric oxygen therapy for fibromyalgia and chronic fatigue is not a one-session intervention, and individual responses vary. Most clinical protocols involve 40 sessions over 8 weeks, with many patients reporting progressive improvements in pain levels, sleep quality, energy, and mental clarity. Some patients with severe sensitivity or deconditioning benefit from lower initial pressures, gradually titrated upward. NorCal Hyperbarics in Concord, CA conducts thorough intake assessments to design HBOT pain management and chronic fatigue protocols tailored to each patient's presentation.

Ready to start your healing journey at NorCal Hyperbarics?

Our experienced clinical team in Concord, CA offers personalized hyperbaric oxygen therapy consultations and HBOT treatment protocols tailored to your specific condition. Serving patients across the Bay Area, Northern California, and the greater Contra Costa County area, NorCal Hyperbarics combines medical-grade technology with individualized care.

Call us: (925) 555-0180   |   Concord, CA   |   www.norcalhbo.com